Uncategorized
R-Tech Ueno: Termination of License Agreements for Unoprostone
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) R-Tech Ueno, Ltd. (RTU) today announced it has signed a termination agreement with Sucampo AG (SAG), one of the subsidiaries of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (Sucampo), which terminates, effective May 6, 2015, all license agreements for unoprostone. (1) Background and Outlines 1) We entered into, on April 23th, 2009, Unoprostone NDA Transfer, Patent and Know-how Licensing, and Data Sharing Agreement, as well as Exclusive Manufact
